Merck’s $4.85 Billion Vioxx Settlement Could Set Industry Standard To Resolve Litigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Agreement to resolve the bulk of Vioxx litigation guards against Merck's future liability, an analyst tells "The Pink Sheet" DAILY.